###begin article-title 0
Direct Inhibition of GSK3beta by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/beta-Catenin Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: SO JKH BJP WW NCH. Performed the experiments: SP SHL HK SY SJL BJP. Analyzed the data: SP JLS JL JKH BJP WW NCH. Contributed reagents/materials/analysis tools: JLS YX JL SO WW NCH. Wrote the paper: SP BJP WW NCH.
###end p 1
###begin p 2
###xml 646 654 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 728 735 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
Wnt/beta-catenin signaling plays a central role in development and is also involved in a diverse array of diseases. Binding of Wnts to the coreceptors Frizzled and LRP6/5 leads to phosphorylation of PPPSPxS motifs in the LRP6/5 intracellular region and the inhibition of GSK3beta bound to the scaffold protein Axin. However, it remains unknown how GSK3beta is specifically inhibited upon Wnt stimulation. Here, we show that overexpression of the intracellular region of LRP6 containing a Ser/Thr rich cluster and a PPPSPxS motif impairs the activity of GSK3beta in cells. Synthetic peptides containing the PPPSPxS motif strongly inhibit GSK3beta in vitro only when they are phosphorylated. Microinjection of these peptides into Xenopus embryos confirms that the phosphorylated PPPSPxS motif potentiates Wnt-induced second body axis formation. In addition, we show that the Ser/Thr rich cluster of LRP6 plays an important role in LRP6 binding to GSK3beta. These observations demonstrate that phosphorylated LRP6/5 both recruits and directly inhibits GSK3beta using two distinct portions of its cytoplasmic sequence, and suggest a novel mechanism of activation in this signaling pathway.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 151 154 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Wodarz1">[1]</xref>
###xml 286 289 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-He1">[2]</xref>
###xml 417 420 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-He1">[2]</xref>
###xml 523 526 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Aberle1">[3]</xref>
###xml 528 531 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Orford1">[4]</xref>
###xml 627 630 600 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Bienz1">[5]</xref>
###xml 740 743 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
###xml 745 748 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Tamai1">[7]</xref>
The Wnt/beta-catenin signaling pathway is essential for normal development, and is inappropriately activated in a number of cancers and other diseases [1]. This signaling pathway functions by regulating the phosphorylation and degradation of the transcription co-activator beta-catenin [2]. In the absence of Wnt, beta-catenin is phosphorylated by GSK3beta in a complex that includes Axin, GSK3beta, and beta-catenin [2]. Phosphorylated beta-catenin is targeted for degradation via phosphorylation-dependent ubiquitination [3], [4]. Wnt stimulation shuts off beta-catenin degradation by inhibiting GSK3beta in the Axin complex [5]. This inhibition is believed to be the key event in the activation of the Wnt/beta-catenin signaling pathway [6], [7].
###end p 4
###begin p 5
###xml 194 197 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Tamai1">[7]</xref>
###xml 198 201 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Kikuchi1">[9]</xref>
###xml 467 471 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng1">[10]</xref>
###xml 473 477 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Bilic1">[11]</xref>
###xml 569 573 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng1">[10]</xref>
###xml 626 630 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 632 636 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
###xml 752 756 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mani1">[14]</xref>
Wnt/beta-catenin signal transduction is triggered at the plasma membrane by two distinct receptors, the serpentine receptor Frizzled, and the single-transmembrane receptor LRP6 or LRP5 (LRP6/5) [7]-[9]. The extracellular ligand Wnt is thought to promote the assembly of Frizzled, LRP6/5, the cytoplasmic protein Dishevelled and the Axin complex, resulting in the sequential phosphorylation of two Ser/Thr residues in each of five cytoplasmic PPPSPxS motifs of LRP6/5 [10], [11]. The PPPSPxS motif was proposed to be dually-phosphorylated by membrane-recruited GSK3beta [10] in the Axin complex and membrane-localized CK1gamma [12], [13]. The dually-phosphorylated PPPSPxS motifs are known to mediate the interaction between LRP6/5 and the Axin complex [14], which somehow leads to the activation of the Wnt/beta-catenin pathway.
###end p 5
###begin p 6
###xml 311 315 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi1">[15]</xref>
###xml 427 435 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 622 626 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi2">[16]</xref>
###xml 869 873 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cselenyi1">[17]</xref>
###xml 1140 1144 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 1340 1344 1316 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 114 119 <span type="species:ncbi:9606">human</span>
It was previously reported that the overexpression of the intracellular region of LRP6 (residues 1417-1613 of the human sequence), a region that contains a Ser/Thr rich cluster and five PPPSPxS motifs, constitutively activated Wnt/beta-catenin signaling and potentiated Wnt3a-induced Wnt/beta-catenin signaling [15]. This group also reported that the purified intracellular region of LRP6/5 attenuated GSK3beta activity by 20% in vitro, strongly indicating that this region of LRP6/5 contains the inhibitory sequence targeting GSK3beta and is thus responsible for activating the Wnt/beta-catenin signaling pathway in cell [16]. Very recently, it was reported that an intracellular region of LRP6, which contains the Ser/Thr rich cluster and the five PPPSPxS motifs, inhibits the phosphorylation of beta-catenin by GSK3beta, and that an intact PPPSPxS motif is required [17]. Davison et al. reported that a truncated receptor containing a transmembrane domain and a shorter fragment of LRP6 (residues 1460-1505; referred to as miniC), including the Ser/Thr rich cluster and the first PPPSPxS motif, can activate the Wnt/beta-catenin pathway [12]. In particular, they observed CK1-dependent phosphorylation of the PPPSPxS motif and the recruitment of Axin to the membrane, identifying these steps as crucial for the activation of the pathway [12]. However, the actual mechanism by which the GSK3beta is inhibited in the Wnt signaling pathway has been obscure.
###end p 6
###begin p 7
In this study, we examine the actions of the intracellular region of LRP6/5 on GSK3beta in Wnt/beta-catenin signaling. We find that phosphorylated LRP6 binds to and directly inhibits GSK3beta, and that GSK3beta can bridge LRP6 and Axin. These findings lead to a reinterpretation of earlier studies and allow us to propose a molecular mechanism for the activation of the Wnt/beta-catenin signaling pathway.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
The LRP6 PPPSPxS motif can inhibit GSK3beta both toward beta-catenin and glycogen synthase
###end title 9
###begin p 10
###xml 421 425 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 427 431 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
We hypothesized that the intracellular LRP6 region acts as a direct GSK3beta inhibitor in Wnt/beta-catenin signal propagation. Within the intracellular region of LRP6, the miniC region of LRP6, especially the PPPSPxS motif, might be the GSK3beta inhibitory sequence; replacement of the cytoplasmic domain of LRP6 with this region can induce Wnt/beta-catenin signaling even in the absence of the LRP6 extracellular region [12], [13].
###end p 10
###begin p 11
###xml 82 89 82 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1A</xref>
###xml 168 174 168 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1</xref>
###xml 304 310 304 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1</xref>
###xml 354 368 354 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Figs. 1B and C</xref>
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s001">Figs. S1</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s002">S2</xref>
###xml 614 621 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1B</xref>
###xml 626 633 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s001">Fig. S1</xref>
###xml 807 814 795 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1B</xref>
###xml 819 826 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s001">Fig. S1</xref>
###xml 958 965 940 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1C</xref>
###xml 970 977 952 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s002">Fig. S2</xref>
###xml 1233 1237 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cselenyi1">[17]</xref>
###xml 1518 1525 1494 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1D</xref>
###xml 802 805 <span type="species:ncbi:9685">cat</span>
To test our hypothesis, we constructed a GFP-fusion protein based on LRP6-miniCL (Fig. 1A), which is similar to the miniC construct (this protein is called GFP-miniCL; Fig. 1). We also constructed a mutant of LRP6-miniCL containing an Ala substitution at Ser1490 as a GFP-fusion construct (GFP-miniCLMT; Fig. 1). We transfected the constructs into A549 (Figs. 1B and C) and HepG2 cells (Figs. S1 and S2) and analyzed the distribution, expression, and phosphorylation state of each construct, and their effects on beta-catenin. Both wild type and mutant miniCL were evenly distributed throughout the cytoplasm (GF; Fig. 1B and Fig. S1). However, only wild-type miniCL dramatically increased the total amount of cellular beta-catenin and promoted the translocation of beta-catenin into the nucleus (beta-cat; Fig. 1B and Fig. S1). We consistently observed an increased level of beta-catenin with the miniCL transfection in western blot analyses (beta-catenin; Fig. 1C and Fig. S2). These observations are consistent with the results of Cselenyi et al., who used the LRP6 cytoplasmic region containing the Ser/Thr rich cluster and five PPPSPxS motifs, and variant in which the first Ser residue of each PPPSPxS motif is replaced by Ala [17]. To confirm the activation of the Wnt/beta-catenin signaling pathway, we measured the transcriptional activity of beta-catenin using luciferase in 293 cells. Forced cytoplasmic expression of wild type miniCL, but not the mutant miniCLMT, significantly induced TOP-flash activity (Fig. 1D). These results suggest that the LRP6 miniCL works as an inhibitor of GSK3beta regardless of its cellular localization, and that the PPPSPxS motif plays a crucial role in this effect.
###end p 11
###begin title 12
LRP6 constructs and their cytoplasmic overexpression in cell.
###end title 12
###begin p 13
###xml 1526 1529 1490 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP</italic>
###xml 1545 1548 1509 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOP</italic>
###xml 1958 1959 1919 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1968 1969 1929 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) Schematic representation of the full-length LRP6 and amino acid sequences of LRP6 intracellular fragments used in this study. The Ser/Thr rich cluster and PPPSPxS motif are underlined in each sequence. Phosphorylated residues are highlighted. (B) Cytosolic overexpression of the LRP6 constructs. A549 cells in which control (empty vector, EV, encoding only GFP), miniCL and miniCLMT were transfected as GFP fusion proteins. Control, miniCL and miniCLMT were detected through the green fluorescence from GFP. beta-Catenin was detected using an anti-beta-catenin antibody, and the nuclei were detected by DAPI staining. (C) Western blotting analysis from the transfected A549 cells used in (B). Labels at the left side of blots indicate the antibody used for detection of the corresponding protein. Endogenous beta-catenin was detected by an anti-beta-catenin antibody. p-GS indicates the level of the phosphorylated GS by GSK3beta, detected by anti-glycogen synthase (Ser641) antibody. p-S9-GSK3beta indicates the phosphorylated Ser9 of GSK3beta, and was detected by anti-phospho GSK3beta (Ser9) antibody. Levels of transfected proteins were detected using monoclonal GFP antibody, indicated by GFP. Total cellular levels of GS and GSK3beta were measured by anti-GS antibody and anti-GSK3beta antibody, which are indicated by t-GS and t-GSK3beta, respectively. Actin is shown as a loading control. (D) Activation of Wnt/beta-catenin signaling, which was measured by the Top-flash luciferase activity. Either the top-flash (TOP) or fop-flash (FOP) luciferase reporter and each construct were transfected into 293 cells. The luciferase activities were measured after 24 h of the transfection. Error bars represent standard deviation from 4 independent experiments. Statistical analysis revealed that overexpression of the miniCL construct significantly activated Wnt/beta-catenin signaling compared to that of the empty vector and the miniCLMT construct (* p<0.01, # p<0.01).
###end p 13
###begin p 14
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1C</xref>
###xml 203 210 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1C</xref>
###xml 359 363 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Ding1">[18]</xref>
The wild-type miniCL, but not the mutant miniCLMT, also suppressed phosphorylation of glycogen synthase (GS; p-GS in Fig. 1C) without the induction of phosphorylation of Ser9 in GSK3beta (p-S9-GSK3beta; Fig. 1C). Suppression of GS phosphorylation normally occurs when GSK3beta is phosphorylated at Ser9 by AKT as a part of the insulin/IGF-1 signaling pathway [18]. Our data indicate that the miniCL protein can inhibit GSK3beta independently of AKT activity when this LRP6 fragment is overexpressed in the cytoplasm, implying that it can act as a general inhibitor of GSK3beta. Note that under physiological conditions, such inhibition would not occur due to the localization of the LRP6/GSK3beta/Axin complex at the plasma membrane (see below).
###end p 14
###begin title 15
###xml 66 74 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Phosphorylated PPPSPxS of LRP6/5 motif directly inhibits GSK3beta in vitro
###end title 15
###begin p 16
###xml 186 194 180 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 242 244 236 238 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</underline>
###xml 242 244 236 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>pS</underline></bold>
###xml 246 248 240 242 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pT</underline>
###xml 246 248 240 242 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>pT</underline></bold>
###xml 349 350 343 344 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 349 350 343 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 352 354 346 348 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pT</underline>
###xml 352 354 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>pT</underline></bold>
###xml 367 369 361 363 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</underline>
###xml 367 369 361 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>pS</underline></bold>
###xml 371 372 365 366 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 371 372 365 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 410 411 404 405 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 410 411 404 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 413 414 407 408 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 413 414 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 475 482 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1A</xref>
###xml 538 546 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 961 968 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s003">Fig. S3</xref>
###xml 1023 1030 996 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s004">Fig. S4</xref>
###xml 1063 1071 1036 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s003">Figs. S3</xref>
###xml 1073 1075 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s004">S4</xref>
###xml 1077 1079 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s005">S5</xref>
###xml 1081 1083 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s006">S6</xref>
###xml 1085 1087 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s007">S7</xref>
###xml 1355 1362 1314 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2A</xref>
###xml 1518 1525 1477 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2A</xref>
###xml 1647 1654 1602 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2A</xref>
###xml 1745 1752 1700 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2A</xref>
###xml 2131 2135 2080 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
Since phosphorylation of the PPPSPxS motif in the miniCL region of LRP6/5 is correlated with the inhibition of GSK3beta, we asked whether the PPPSPxS motif can directly inhibit GSK3beta in vitro. We synthesized one dually-phosphorylated (NPPPpSPApTERSH, where pS or pT designates a phosphorylated Ser or Thr residue), two singly-phosphorylated (NPPPSPApTERSH and NPPPpSPATERSH) and one non-phosphorylated (NPPPSPATERSH) peptides derived from the first PPPSPxS motif of LRP6 (Fig. 1A). To measure the GSK3beta activity toward beta-catenin in vitro, we utilized a beta-catenin N-terminal fragment (residues 1-133), whose Ser45 was prephosphorylated by CK1, as a substrate (Ha et al., 2004). Each synthetic peptide was added to a reaction mixture containing the purified GSK3beta enzyme and the substrate beta-catenin N-terminal fragment. The GSK3beta activity was determined through measurement of the intensity of the supershifted (retarded) beta-catenin bands (Fig. S3), which represent the phosphorylated product species (Fig. S4), on an SDS-polyacrylamide gel (Figs. S3, S4, S5, S6, S7). The dually-phosphorylated peptide showed a strong inhibitory effect on GSK3beta in a concentration-dependent manner (1-100 microM), while the non-phosphorylated peptide did not show any inhibitory effect on the GSK3beta activity at concentrations up to 100 microM (Fig. 2A). The two singly-phosphorylated peptides showed distinct inhibitory effects. Whereas the peptide phosphorylated at the second Ser/Thr residue [PPPSPx(p)S; Fig. 2A] exhibited only a marginal inhibitory effect at 100 microM, the peptide phosphorylated at the first Ser/Thr [PPP(p)SPxS; Fig. 2A] exhibited a strong inhibitory effect close to that of the dually-phosphorylated peptide (Fig. 2A). Our results demonstrate that the dually-phosphorylated PPPSPxS motif directly inhibits GSK3beta, and that phosphorylation at the first Ser residue plays a more important role. This corresponds well with the results of Zeng et al., who reported that the first Ser residue in the PPPSPxS motif has a more important role in Wnt/beta-catenin signaling than the second Ser residue [13]. Since the non-phosphorylated peptide does not inhibit, the inhibition is not due to competition between this potential alternative substrate and the beta-catenin substrate.
###end p 16
###begin title 17
Direct inhibition of GSK3beta on the beta-catenin N-terminal fragment by LRP6 PPPSPxS peptides.
###end title 17
###begin p 18
###xml 193 199 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane 1</italic>
###xml 328 335 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s005">Fig. S5</xref>
###xml 382 383 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 548 549 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 674 675 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1248 1255 1212 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s006">Fig. S6</xref>
###xml 1355 1359 1316 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Left</italic>
###xml 1453 1457 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Fraser1">[35]</xref>
###xml 1546 1551 1485 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
###xml 1580 1592 1519 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST-Axin GBD</italic>
###xml 1936 1944 1858 1866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1979 1986 1901 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s007">Fig. S7</xref>
###xml 815 820 <span type="species:ncbi:10090">mouse</span>
###xml 1564 1569 <span type="species:ncbi:10090">mouse</span>
(A) GSK3beta activity is inhibited by the LRP6 PPPSPxS peptides depending on the phosphorylation state of the LRP6 motif. The graph is plotted as a percentage of uninhibited GSK3beta activity (Lane 1) from 4-7 independent experiments; the standard deviation is indicated by error bars. Gels used in this experiment are shown in Fig. S5. (B) Measurement of the inhibition constant (Ki) of the dually-phosphorylated LRP6 peptide. Varying concentrations (0, 1, 3, 10, and 30 microM) of the dually-phosphorylated LRP6 peptide were used to measure the Ki value. The data points are the mean of three independent experiments. The progressive increase in slope indicates that the Ki for the peptide is approximately13 microM. (C) The dually-phosphorylated PPPSPxS peptide inhibits the GSK3beta-mediated phosphorylation of mouse Axin fragment (residues 512-650). The intensities of the Coomassie-blue stained phosphorylated bands were quantitatively analyzed. The purified Axin fragment (5 microg) was used as a substrate in the same reaction buffer as in (A). The graph is plotted as a percentage of uninhibited GSK3beta activity from 3 independent experiments; the standard deviation is indicated by error bars. Gels used in this experiment are shown in Fig. S6. (D) GSK3beta is inhibited by the phosphorylated LRP6 motif independently of the Axin GBD protein (Left). Binding of Axin GBD to GSK3beta is fully saturated at above 2.5 microM of the Axin protein [35], where approximately20% of the GSK3beta activity was inhibited by the Axin GBD protein (Right). GST-fused mouse Axin GBD (GST-Axin GBD, residues 512-530) was used in these experiments. The graph is plotted as relative GSK3beta activities from three independent experiments. Error bars indicate the standard deviation. Because the binding constant of Axin GBD domain to GSK3beta is about 1 microM, most GSK3beta is bound to Axin GBD domain at above 2.5 microM of Axin GBD domain in vitro. A representative gel is shown in Fig. S7. Binding of Axin GBD to GSK3beta was confirmed by the far western blotting experiment (Data not shown).
###end p 18
###begin p 19
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zhou1">[19]</xref>
###xml 155 156 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 307 308 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 390 394 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Dajani1">[20]</xref>
###xml 396 403 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2B</xref>
Based on steady-state kinetic analyses [19], the dually phosphorylated LRP6 peptide competitively inhibits GSK3beta with an apparent inhibition constant (Ki) of 13 microM. Thus, the phosphorylated LRP6 motif is a much stronger inhibitor of GSK3beta than the phosphorylated N-terminal fragment of GSK3beta (Ki approximately700 microM), which is a known pseudosubstrate inhibitor of GSK3beta [20] (Fig. 2B).
###end p 19
###begin p 20
###xml 371 379 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 384 391 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 391 395 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Jho1">[21]</xref>
###xml 409 416 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2C</xref>
###xml 802 810 781 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 810 814 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi2">[16]</xref>
###xml 1194 1202 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
It was noted above that cytoplasmically expressed miniCL inhibits phosphorylation of GS. To further test whether the dually-phosphorylated PPPSPxS peptide can act as a general inhibitor of GSK3beta, we tested its effect on GSK3beta-mediated phosphorylation of an Axin fragment (mouse Axin amino acids 512-650), in which Ser614 is the only site phosphorylated by GSK3beta in vitro and in vivo[21]. As shown in Fig. 2C, the phosphorylated PPPSPxS peptides inhibited GSK3beta-mediated phosphorylation of the Axin fragment as efficiently as on the primed beta-catenin N-terminal fragment substrate. This result is consistent with the observation that the intracellular region of LRP6 decreased GSK3beta phosphorylation of an unprimed substrate Tau protein and the primed substrate full-length beta-catenin in vitro[16]. In addition, the phosphorylated PPPSPxS peptides did not show any inhibitory effect on CK1 when we use the unphosphorylated beta-catenin fragment as a substrate (data not shown), confirming that the phosphorylated PPPSPxS peptide inhibits only GSK3beta. Collectively, these data suggest that the phosphorylated PPPSPxS motif of LRP6/5 can act as a general inhibitor of GSK3beta in vitro.
###end p 20
###begin title 21
Axin-bound GSK3beta is inhibited by the phosphorylated LRP6 PPPSPxS motifs
###end title 21
###begin p 22
###xml 121 129 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 407 411 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Dajani2">[22]</xref>
###xml 469 476 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2D</xref>
###xml 551 555 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Thomas1">[23]</xref>
###xml 569 576 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2D</xref>
###xml 829 833 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Dajani2">[22]</xref>
###xml 839 847 800 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 952 959 910 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We next sought to determine if the phosphorylated LRP6 motifs are capable of inhibiting GSK3beta in the Axin complex. An in vitro kinase assay with Axin-bound GSK3beta was performed by adding the purified GSK3beta binding domain (GBD) of Axin to the reaction mixture. Although full-length Axin increases GSK3beta activity toward full-length beta-catenin through its scaffolding of GSK3beta and beta-catenin [22], the Axin GBD domain itself slightly inhibited GSK3beta (Fig. 2D), which is consistent with the reduced activity of Fratide-bound GSK3beta [23]. As shown in Fig. 2D, the dually-phosphorylated PPPSPxS peptide inhibits Axin-bound GSK3beta similarly to free GSK3beta. This result is consistent with the crystal structure of GSK3beta complexed with Axin, which shows that Axin does not occupy the active site of GSK3beta [22]. The in vitro inhibition of Axin-bound GSK-3beta indicates that the phosphorylated PPPSPxS motifs of LRP6/5 can be an in vivo inhibitor of GSK3beta in Wnt/beta-catenin signaling.
###end p 22
###begin title 23
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
Microinjection of the peptide containing the phosphorylated PPPSPxS motif into the Xenopus embryo potentiates Wnt/beta-catenin signaling
###end title 23
###begin p 24
###xml 94 101 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 109 113 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Dominguez1">[24]</xref>
###xml 194 201 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 232 236 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-He2">[25]</xref>
###xml 253 260 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 360 367 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 406 413 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 539 545 530 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g003">Fig. 3</xref>
###xml 635 641 626 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g003">Fig. 3</xref>
###xml 722 728 713 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g003">Fig. 3</xref>
###xml 920 927 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1088 1095 1079 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
It is well established that Wnt signaling reduces GSK3beta activity during development of the Xenopus embryo [24], and that the suppressed activity of GSK3beta induces a second body axis in the Xenopus embryo in the response to Wnt [25]. To examine the in vivo effect of the PPPSPxS motif on Wnt/beta-catenin signaling, we injected the synthetic peptides into Xenopus embryos, along with a small amount of Xenopus Wnt8 that is insufficient to induce second body axis formation on its own. The dually-phosphorylated peptide [PPP(p)SPx(p)S; Fig. 3] strongly induced the second body axis, whereas the non-phosphorylated peptide [PPPSPxS; Fig. 3] did not. The peptide phosphorylated at only the first Ser residue [PPP(p)SPxS; Fig. 3] induced the second body axis with an efficiency comparable to that of the dually-phosphorylated peptide. This result indicates that the phosphorylated PPPSPxS motif can induce Wnt signaling in vivo. Although the amount injected is likely to be higher than physiological concentrations, it is interesting that microinjection of each peptide in the absence of Xenopus Wnt8 did not induce a second body axis (data not shown). It is likely that a slight reduction in the GSK3beta activity due to the activity of the exogenous Wnt on the endogenous LRP6/5 is required for the peptide to cause a sufficient inhibition of GSK3beta to trigger Wnt/beta-catenin signaling. Moreover, even if the amount of peptide injected is well above physiological concentrations, the effect is specific to the phosphorylated peptide. Thus, the peptide injection experiments, when considered with the experiments using purified proteins, indicate that the phosphorylated PPPSPxS motif directly inhibits GSK3beta and leads to the activation of beta-catenin.
###end p 24
###begin title 25
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
The effect of the injected PPPSPxS peptides to the Xenopus embryos.
###end title 25
###begin p 26
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XWnt8</italic>
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 424 431 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Xenopus Wnt8 protein (XWnt8; 0.5 pg) was co-microinjected with each peptide (1 ng) into the ventrovegetal region of Xenopus embryos. Representative embryo pictures are shown in the left panel, and the diagram shows the ratio of the phenotypes (normal shape, partial and complete second axis duplication) in the right panel. Although the injected peptides would be diluted and degraded as the cells divide due to lack of the de novo biosynthesis, the dually and singly-phosphorylated PPPSPxS peptides dramatically increased partial and complete second body axis.
###end p 26
###begin p 27
###xml 365 369 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cselenyi1">[17]</xref>
It was recently reported that injection of a recombinant portion of the LRP6 cytoplasmic region containing the Ser/Thr rich cluster and the five PPPSPxS motifs induced a second body axis as effectively as the phosphorylated PPPSPxS peptide in the absence of the exogenously-added Wnt ligand, even when the LRP6 protein was not prephosphorylated by GSK3beta and CK1 [17]. It seems likely that the longer fragment of the LRP6 cytoplasmic region is phosphorylated by endogenous kinases in the embryo, and has a stronger inhibitory effect on GSK3beta due to the multiple PPPSPxS motifs. Also, as we show below, the Ser/Thr-rich region upstream of the PPPSPxS motifs, may have an important role in this process.
###end p 27
###begin title 28
GSK3beta preferentially binds to the phosphorylated intracellular region of LRP6
###end title 28
###begin p 29
###xml 223 226 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
###xml 228 232 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 234 238 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
###xml 240 244 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi2">[16]</xref>
###xml 337 341 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
###xml 343 347 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi2">[16]</xref>
###xml 433 441 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 441 444 429 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
###xml 578 581 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
###xml 630 634 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Dajani2">[22]</xref>
###xml 308 313 <span type="species:ncbi:4932">yeast</span>
###xml 549 554 <span type="species:ncbi:4932">yeast</span>
###xml 655 660 <span type="species:ncbi:4932">yeast</span>
The evidence above suggests that the phosphorylated PPPSPxS motifs of the LRP6/5 intracellular region competitively inhibit GSK3beta. The intracellular region of LRP6/5 has been implicated in binding both GSK3beta and Axin [6], [12], [13], [16]. Whereas GSK3beta bound to LRP6 or 5 in the absence of Axin in yeast two-hybrid experiments [13], [16], GSK3beta dramatically increased the interaction of Axin with LRP6 or 5 in cells and in vitro[6]. Moreover, both the GBD and DIX domains of Axin were present in constructs that interacted with LRP5 in yeast two-hybrid experiments [6]. The Axin-binding site found in vertebrate GSK3 [22] is conserved in the yeast homolog. These observations suggest that GSK3 can associate directly with LRP6 and bridge LRP6 to Axin.
###end p 29
###begin p 30
###xml 221 228 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1A</xref>
###xml 767 773 746 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g004">Fig. 4</xref>
###xml 903 910 882 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g004">Fig. 4A</xref>
###xml 910 915 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
###xml 1169 1170 1145 1146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
We first investigated whether the intracellular region of LRP6 binds to GSK3beta in a phosphorylation-dependent manner. To detect binding, we used recombinant GST-fused LRP6 fragments (miniCL, miniCLMT, PPPSPxS, PPPAPxS; Fig. 1A) and GSK3beta proteins in a far western binding assay. This assay is appropriate as the LRP6 cytoplasmic region is expected to be natively unstructured and therefore should not suffer from denaturation artifacts. Prior to the binding reaction, the GST-fused LRP6 fragments were phosphorylated by GSK3beta and CK1 and transferred to a PVDF membrane. The membrane was incubated with GSK3beta, and bound GSK3beta was detected with an anti-GSK3beta antibody. GSK3beta bound to GST-miniCL and GST-miniCLMT, but not GST-PPPSPxS or GST-PPPAPxS (Fig. 4). Comparison with LRP6 that had not been phosphorylated revealed that phosphorylation enhanced the binding by four to five fold (Fig. 4ARight). Since the S1490A mutation does not affect binding, these results suggest that the Ser/Thr rich cluster present in miniCL plays more important role in mediating the phosphorylation-dependent interaction of LRP6 with GSK3beta. Also, given the measured Ki value of the single PPPSPxS motif, it was expected that the single PPPSPxS motif might exert a limited role in recruiting the GSK3beta.
###end p 30
###begin title 31
Phosphorylation-dependent binding of the LRP6 intracellular region to GSK3beta in the absence and presence of Axin.
###end title 31
###begin p 32
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lanes</italic>
###xml 251 259 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Left top</italic>
###xml 440 445 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lanes</italic>
###xml 838 849 816 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Left bottom</italic>
###xml 1053 1058 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
###xml 1524 1532 1476 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">His-Axin</italic>
(A) GST (Lane 1), GST-fused miniCL (Lane 3; GST-miniCL), GST-fused miniCLMT (Lane 5; GST-miniCLMT), and their phosphorylated forms (Lanes 2, 4, 6; indicated by "phos") were loaded onto an SDS-polyacrylamide gel, and then transferred to PVDF membrane (Left top). Because GST-fused PPPSPxS and PPPAPxS were not phosphorylated by GSK3beta and CK1 (data not shown), we only applied the GSK3beta- and CK1-treated GST-PPPSPxS or its mutant form [Lanes 7, 8; indicated by (phos)] to the gel, since the untreated forms would be redundant. The phosphorylated protein bands show an upshifted mobility on the gel. The PVDF membrane was incubated with 1 microg/ml of GSK3beta to allow GSK3beta to bind to the proteins in the membrane. The bound GSK3beta was visualized on the transferred proteins by western blotting using an anti-GSK3beta antibody (Left bottom), and the GSK3beta protein used to obtain the phosphorylated forms of each protein is indicated by GSK3beta*. The band intensities of bound GSK3beta were measured from the three independent experiments (Right). (B) The Axin GBD domain does not affect the binding of GSK3beta to the miniCL region of LRP6. The phosphorylated GST-fused miniCL was transferred to PVDF membrane, and the membrane was incubated with GSK3beta (0.1 microg/ml) and GST-fused Axin GBD domain protein (0, 10 microM). Error bars indicate the standard deviation from three independent experiments. (C) GSK3beta mediates the binding of an Axin fragment to LRP6 miniCL region. A His-tagged Axin fragment (His-Axin; residues 512-650) including the GBD and the beta-catenin binding domain (BBD) was tested if it directly binds to LRP6 miniCL region or its binding is mediated by GSK3beta. Fifteen microg of GST-miniCL was transferred to a PVDF membrane, and the membrane was incubated with GSK3beta (2 microg/ml) and/or His-Axin (12 microg/ml) in TBST containing 1% skim milk. The Axin fragment was bound to LRP6 miniCL only in the presence of GSK3beta.
###end p 32
###begin p 33
###xml 288 295 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g004">Fig. 4B</xref>
###xml 469 477 451 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 619 626 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g004">Fig. 4C</xref>
###xml 844 851 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
To investigate whether the Axin-bound GSK3beta is able to bind to the phosphorylated LRP6 fragments (miniCL), we incubated GSK3beta with excess Axin GBD protein to saturate its binding to GSK3beta and then tested the binding of GSK3beta and LRP6 using the same far western blot analysis (Fig. 4B). Binding of GSK3beta to the LRP6 fragment was not affected by the presence of Axin, indicating that the Axin GBD, GSK3beta, and LRP6 miniCL proteins form a ternary complex in vitro. Furthermore, we observed that an Axin fragment including the GBD was bound to the LRP6 miniCL fragment only when GSK3beta was co-incubated (Fig. 4C), demonstrating that GSK3beta mediates the association of the Axin fragment with the LRP6 intracellular region. Taken together, we propose that the GSK3beta plays an important role in mediating Axin binding to LRP6/5 in vivo mainly through the Ser/Thr rich cluster of LRP6/5.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 187 188 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 215 216 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 364 365 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 401 405 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Takahashi1">[26]</xref>
###xml 504 512 479 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
Here we have provided evidence that the phosphorylated PPPSPxS motif of LRP6/5 directly inhibits GSK3beta. The dually-phosphorylated PPPSPxS motif acts as a competitive inhibitor with a Ki of 13 microM. Given this Ki value, the inhibitory effect of phosphorylated LRP6 on GSK3beta is relatively low compared to other cytoplasmic protein inhibitors, such as XIAP (Ki toward caspase-3 approximately2 nM [26]), although it is a much stronger inhibitor than the phosphorylated N-terminal segment of GSK3beta in trans. However, the weak inhibitory effect of the phosphorylated LRP6 on GSK3beta could become important when GSK3beta and LRP6 are both localized to the membrane, which would bring the enzyme and its inhibitor into close proximity. Moreover, the five PPPSPxS motifs could enhance the avidity of the interaction with GSK3.
###end p 35
###begin p 36
###xml 756 763 716 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2C</xref>
###xml 1144 1145 1094 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1289 1297 1239 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Cselenyi et al. (2008) found that the recombinant, nonphosphorylated LRP6 intracellular region at approximately4 microM can inhibit beta-catenin phosphorylation by GSK3beta, but not Tau, another GSK3beta substrate, which led these authors to propose that GSK3beta phosphorylates LRP6 and that the phosphorylated species somehow specifically interferes with the beta-catenin-GSK3beta interaction rather than inhibiting the kinase. They argue that the inhibition of GSK3beta observed by Mi et al. (2006) may have been due to the use of supraphysiological concentrations, although the concentrations used in that study were not reported. We have shown that phosphorylated LRP6 inhibits GSK3beta activity towards another substrate, Axin, in a purified system (Fig. 2C), arguing against a beta-catenin specific inhibitory activity. We also see inhibition of glycogen synthase when the LRP6 cytoplasmic fragment is overexpressed in cells. Although in this case a free cytosolic LRP6 motif is clearly not physiological, taken with the other data it is clear that the phosphorylated motif can act as a competitive inhibitor of GSK3beta. The 13 microM Ki is consistent with the findings of Cselenyi et al. when the avidity of the 5 PPPSPxS motifs is considered. Although the relevant concentration in vitro is not known, particularly given the formation of scaffolding complexes at the plasma membrane, it is clear that the phosphorylated motifs act as potent inhibitors.
###end p 36
###begin p 37
###xml 128 132 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Wallingford1">[27]</xref>
###xml 346 350 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cliffe1">[28]</xref>
###xml 351 355 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Yanagawa1">[30]</xref>
The cytoplasmic scaffold protein Dishevelled is an indispensible component downstream of Frizzled in Wnt/beta-catenin signaling [27]. A large body of evidence suggests that Dishevelled is responsible for the direct recruitment of Axin to the membrane in Wnt/beta-catenin signaling, through the interaction of the Dishevelled and Axin DIX domains [28]-[30]. In this study, we found that the miniCL intracellular region of LRP6/5 has two functional modules, each regulated by their phosphorylation state: the Ser/Thr rich cluster appears to contribute to the binding of GSK3beta, and the PPPSPxS motifs regulate GSK3beta activity. The interaction of the Ser/Thr rich cluster with GSK3beta suggests that the Ser/Thr rich cluster of LRP6/5 and Dishevelled may synergize in the recruitment of the GSK3beta-Axin complex to the membrane upon Wnt stimulation. Concurrently, GSK3beta co-localized with Axin at the membrane would be inhibited by the phosphorylated PPPSPxS motifs of LRP6/5.
###end p 37
###begin p 38
###xml 140 146 137 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g005">Fig. 5</xref>
###xml 1296 1300 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Ding1">[18]</xref>
###xml 1302 1306 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Pearl1">[31]</xref>
Our findings suggest a mechanism to account for the role of phosphorylated LRP6 motifs in the initial events of Wnt/beta-catenin signaling (Fig. 5). Binding of Wnt to the Frizzled and LRP6/5 receptors promotes binding of Dishevelled to the cytoplasmic region of Frizzled. This membrane-localized Dishevelled recruits the Axin complex mainly through the Axin-Dishevelled interaction and partly through the LRP6 Ser/Thr rich cluster-GSK3beta interaction. The membrane-localized GSK3beta in the Axin complex, together with CK1gamma, phosphorylates the intracellular region of LRP6/5, including the Ser/Thr rich cluster and the five PPPSPxS motifs. The phosphorylated Ser/Thr rich cluster of LRP6/5 has a higher affinity for GSK3beta, and may help to maintain the Axin complex at the membrane in conjunction with the Dishevelled-Axin interaction. Finally, GSK3beta in the plasma membrane-localized Axin complexes is inhibited by the phosphorylated PPPSPxS motifs of LRP6/5. According to this model, the cytoplasmic GSK3beta molecules involved in insulin/IGF-1 signaling would not be recruited to the membrane because of the lack of the Dishevelled-Axin interaction. As such, this model is compatible with the observation that free cytoplasmic GSK3beta is not inhibited in response to Wnt stimulation [18], [31], thereby insulating the insulin/IGF-1 signaling from the Wnt/beta-catenin signaling pathway.
###end p 38
###begin title 39
A model for the activation of Wnt/beta-catenin signaling.
###end title 39
###begin p 40
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Left</italic>
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fz</italic>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dvl</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Middle</italic>
###xml 624 629 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
Left, simultaneous binding of Wnt to Frizzled (Fz) and LRP6/5 leads to recruitment of Dishevelled (Dvl) to the Frizzled cytoplasmic region. Middle, the Axin complex containing GSK3beta is recruited to the membrane via interactions of Axin with Dishevelled, and also the Ser/Thr rich cluster of LRP6/5 with GSK3beta in the complex. The membrane-recruited GSK3beta, together with the membrane-anchored CK1gamma, phosphorylates the Ser/Thr rich cluster of LRP6. Once the Ser/Thr rich cluster of LRP6/5 is phosphorylated, LRP6/5 makes a greater contribution to the recruitment of the Axin complex due to its increased affinity. Right, the GSK3beta in the Axin complex is inhibited by the phosphorylated PPPSPxS motif in LRP6/5. The phosphorylated Ser/Thr rich cluster is indicated by p in a square, and the phosphorylated PPPSPxS motif is indicated by p in a circle.
###end p 40
###begin p 41
###xml 103 107 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cselenyi1">[17]</xref>
###xml 117 120 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
###xml 122 126 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Davidson1">[12]</xref>
###xml 128 132 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zeng2">[13]</xref>
###xml 134 138 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mi2">[16]</xref>
###xml 530 534 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Cselenyi1">[17]</xref>
###xml 900 903 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Mao1">[6]</xref>
It was previously suggested that the roles of phosphorylated PPPSPxS motif are to recruit beta-catenin [17] and Axin [6], [12], [13], [16], which would lead to inhibition of beta-catenin phosphorylation by GSK3beta. Fluorescence resonant energy transfer between tagged proteins suggested that the LRP6 cytoplasmic region binds to beta-catenin in the cell leading to the proposal that inhibition of beta-catenin phosphorylation results from the association of the LRP6 region with beta-catenin, not from the inhibition of GSK3beta [17]. However, we find that intracellular region of LRP6 directly binds to GSK3beta through the Ser/Thr rich cluster and thereby mediates the recruitment of Axin, suggesting that beta-catenin associates indirectly with LRP6 through GSK3beta and Axin. Likewise, the ability of GSK3beta to bind simultaneously to LRP6 and Axin explains earlier co-immunopreciptiation data [6] that were used to conclude that LRP6 and Axin interact directly. In summary, our results show that the phosphorylated PPPSPxS motif of LRP6 acts as a direct inhibitor of GSK3beta in Wnt/beta-catenin signaling, and suggest a mechanism for stabilization of beta-catenin upon activation of cell surface Wnt receptors.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Plasmids for transfection
###end title 43
###begin p 44
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
DNA fragments encoding LRP6 miniCL (residues 1470-1510 of human LRP6) were obtained from a human cDNA library by PCR, and inserted into the pEGFP-C1 vector (Clontech) using HindIII and BamHI sites of to generate GFP-tagged protein, resulting in pEGFP-miniCL. The LRP6 mutant (S1490A) was generated by PCR-mediated mutagenesis, resulting in pEGFP-miniCLMT.
###end p 44
###begin title 45
Antibodies
###end title 45
###begin p 46
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 168 174 <span type="species:ncbi:9986">rabbit</span>
Antibodies were used according to the manufacturer's instructions. Antibodies used include mouse monoclonal anti-beta-catenin (Santa Cruz), anti-GFP (Santa Crutz), and rabbit polyclonal anti-GSK3beta (Cell signaling), anti-phospho GSK3beta (Ser9) (Cell signaling), anti-phospho LRP6 (Ser1490) (Cell signaling), anti-phospho-glycogen synthase (Ser641) (Cell signaling), anti-GS (Cell signaling), anti-phospho-beta-catenin (Ser45) (Cell signaling), and anti-phospho-beta-catenin (Ser33/37/Thr41) (Cell signaling).
###end p 46
###begin title 47
Transfection and protein analysis
###end title 47
###begin p 48
pEGFP-miniCL and pEGFP-miniCLMT vectors were transfected into A549 cells and HepG2 cells using jetpei according to the manufacturer's protocol (Polyplus transfection). In brief, 2 microg of DNA and jetpei mixtures were added to A549 cells and HepG2 cell and incubated for 3 h under serum-free conditions, and then equal volumes of DMEM containing 20% serum were added. After 24 h incubation, cells were harvested using RIPA (containing protease cocktail). Subsequently, 20 microg of protein lysates were applied to SDS-PAGE. After transferring the proteins to a PVDF membrane, samples were incubated with the appropriate antibodies, according to standard western blot protocol.
###end p 48
###begin title 49
Luciferase assay
###end title 49
###begin p 50
To address the transcriptional activity of beta-catenin, TOP-flash (responsive luciferase vector) and FOP-flash (unresponsive vector), which were kindly provided by Drs. B. Vogelstein and K. Kinzler (Johns Hopkins Univ.), were transfected into 293 cells. Using 10 microl of cell lysate, we performed the luciferase assay using the luciferase assay kit (Promega).
###end p 50
###begin title 51
Immunofluorescence staining
###end title 51
###begin p 52
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
Transfected cells were fixed with 100% methanol for 20 min at -20degreesC. After washing with PBS and subsequent blocking with blocking buffer (PBS+0.05% BSA), fixed cells were incubated with anti-beta-catenin antibody for 2 h at room temperature. After washing with PBS, cells were incubated with a rhodamine-conjugated anti-mouse antibody for 2 h. To visualize nuclei, cells were stained with DAPI for 5 min. After washing with PBS, expression of beta-catenin, GFP, and DAPI were analyzed using fluorescence microscopy.
###end p 52
###begin title 53
Expression and purification of recombinant proteins
###end title 53
###begin p 54
###xml 142 146 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Ha1">[32]</xref>
###xml 220 236 208 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 681 682 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1178 1184 1142 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1512 1518 1476 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 220 236 <span type="species:ncbi:562">Escherichia coli</span>
###xml 268 271 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 396 399 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 896 901 <span type="species:ncbi:10090">mouse</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 1178 1184 <span type="species:ncbi:562">E.coli</span>
###xml 1473 1478 <span type="species:ncbi:10090">mouse</span>
###xml 1512 1518 <span type="species:ncbi:562">E.coli</span>
The catalytic domains of mouse GSK3beta (residues 27-393) and CK1epsilon (residues 1-319) were expressed and purified as previously described [32]. The N-terminal region (residues 1-133) of beta-catenin was expressed in Escherichia coli as a GST-fusion protein with a TEV protease cleavage site and then purified using Glutathione-agarose. Subsequently, the GST tag was cleaved using recombinant TEV protease and was removed by repeated HiTrapQ anion-exchange chromatography. The N-terminal region of beta-catenin was then phosphorylated by incubation with the catalytic domain of CK1epsilon (0.28 mg/ml) at 37degreesC for 20 min in 50 mM Tris buffer (pH 8.0) containing 10 mM MgCl2, 10 mM 2-mercaptoethanol, and 2 mM phenylmethylsulfonylfluoride. The phosphorylated beta-catenin fragment was then further purified using HiTrapQ anion-exchange chromatography to remove the CK1epsilon enzyme. The mouse Axin GBD (residues 512-530), and variants of human LRP6 (miniCL, residues 1470-1510; miniCLMT, residues 1470-1510 with substitution at Ser1490 with Ala; LRP6 PPPSPxS, residues 1485-1497; and LRP6 PPPAPxS, residues 1485-1497 with the substitution at Ser1490) were expressed in E.coli as GST-fusion proteins and purified using Glutathione-agarose and a HiTrapQ anion-exchange chromatographic column. The final buffer for the GST-fusion proteins was changed to 20 mM Tris buffer (pH 8.0) using Centriprep (10 kDa cutoff; Millipore). His-tagged Axin fragment (512-650 in the mouse Axin numbering) was expressed in E.coli, and purified using Ni-NTA affinity and HitrapQ anion exchange chromatographic columns.
###end p 54
###begin title 55
Peptide synthesis
###end title 55
###begin p 56
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g001">Fig. 1A</xref>
Peptides for inhibition assays were prepared by solid-phase synthesis. The amino acid sequence of each peptide is shown in Fig. 1A. The N-terminus and C-terminus of all peptides were modified by biotinylation and amidation, respectively. Biotinylation was accomplished using sulfo-NHS-SS-biotin (Pierce), which allowed reductive cleavage of the 15-mer from the biotin group. The identity and purity of the synthesized peptides were confirmed by mass spectrometry.
###end p 56
###begin title 57
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro GSK3beta activity assay in the presence of synthetic peptides
###end title 57
###begin p 58
###xml 249 250 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 661 668 634 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s003">Fig. S3</xref>
###xml 670 672 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s004">S4</xref>
###xml 674 676 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s006">S6</xref>
###xml 682 684 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s007">S7</xref>
To measure the GSK3beta activity in the presence of each synthetic peptide dissolved in 10% dimethylsulfoxide, 7.5 microl of the reaction mixture was incubated for 30 min at 37degreesC. This reaction mixture contained 50 mM Tris (pH 8.0), 10 mM MgCl2, 10 mM 2-mercaptoethanol, 1 mM ATP, 2 ng of recombinant GSK3beta catalytic domain, 7 microM of the primed beta-catenin N-terminal fragment, and the same volume (0.3 microl) of varying concentrations of each synthetic peptide. After the reaction was stopped by the addition of SDS-loading buffer and immediate boiling, the resultant mixture was applied to a 15% SDS-polyacrylamide gel for analysis. As shown in Fig. S3, S4, S6, and S7, the intensities of the supershifted bands (substrate, product a, product b) on the Coomassie-stained gel were integrated using the program IMAGEQUANT (Molecular Dynamics, USA). To calculate the GSK3beta activity, the intensities of the two product bands were combined according to the number of phosphate groups incorporated by GSK3beta. The lower band (product a) contains one phosphate group (x1), while the upper (product b) band contains two or three phosphate groups (x2.5). To examine the effect of Axin GBD on the inhibitory role of the dually-phosphorylated peptide toward GSK3beta activity, each concentration of GST-fused Axin GBD protein was added in 7.5 microl of the reaction mixture with GSK3beta.
###end p 58
###begin title 59
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Determination of the Ki value of the phosphorylated LRP6 peptide toward GSK3beta
###end title 59
###begin p 60
###xml 80 81 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 649 650 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 701 702 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 704 705 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 722 723 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 732 733 705 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 739 740 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 856 860 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Zhou1">[19]</xref>
Thirty microl of the reaction mixture containing 50 mM Tris (pH 8.0), 10 mM MgCl2, 10 mM 2-mercaptoethanol, 1 mM ATP, 8 ng of recombinant GSK3beta catalytic domain, 6 microM of the primed beta-catenin N-terminal fragment, and varying concentrations of dually-phosphorylated peptide were incubated at 37degreesC. At each time point, 7.5 microl was taken from the reaction mixture for SDS-PAGE. The GSK3beta activity was measured using a Coomassie-stained SDS-polyacrylamide gel, as described above. The initial parts of the activity curves, which show no curvature, were obtained and their slopes were calculated as initial velocities. The apparent Ki value was determined according to the equation: (V0/Vi)-1 = [peptide]/Ki, where V0 and Vi are the initial velocities of the reaction in the absence and in the presence of the dually-phosphorylated peptide [19].
###end p 60
###begin title 61
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis</italic>
###xml 0 14 <span type="species:ncbi:8355">Xenopus laevis</span>
Xenopus laevis embryo manipulations
###end title 61
###begin p 62
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis</italic>
###xml 79 93 79 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis</italic>
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Newport1">[33]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004046-Nieuwkoop1">[34]</xref>
###xml 0 14 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 79 93 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Xenopus laevis was purchased from Xenopus I and Nasco. Eggs were obtained from Xenopus laevis primed with 800 U of human chorionic gonadotropin (Sigma). In vitro fertilization was performed as described previously [33], and the developmental stages of the embryos were determined according to Nieuwkoop and Faber [34]. Microinjection was carried out in 0.33xModified Ringer's (MR) containing 4% Ficoll-400 (GE healthcare) using a Nanoliter Injector (WPI). Injected embryos were cultured in 0.33xMR until stage 8 and then transferred to 0.1xMR until they had reached the appropriate stage.
###end p 62
###begin title 63
Phosphorylation of GST-fusion proteins
###end title 63
###begin p 64
###xml 266 267 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To phosphorylate GST-fusion proteins, 15 microg of each GST-fusion protein was incubated for 4 h at 37degreesC with 0.2 microg of recombinant GSK3beta and 0.4 microg of recombinant CK1epsilon in 10 microl of 50 mM Tris (pH 8.0) buffer containing 5 mM ATP, 10 mM MgCl2 and 10 mM 2-mercaptoethanol.
###end p 64
###begin title 65
Far western blotting analysis
###end title 65
###begin p 66
###xml 469 475 <span type="species:ncbi:9986">rabbit</span>
###xml 528 532 <span type="species:ncbi:9925">goat</span>
###xml 538 544 <span type="species:ncbi:9986">rabbit</span>
GST-fusion proteins (GST-miniCL, GST-miniCLMT, GST-PPPSPxS, GST-PPPAPxS) were subjected to SDS-PAGE and transferred to a PVDF membrane. The membrane was then blocked for 1 h with 5% skim milk in TBST (20 mM Tris (pH 7.6), 137 mM NaCl, 0.05% Tween 20), and rinsed with TBST. Then the membrane was incubated for 3 h with the 1 microg of the recombinant GSK3beta in 1 ml of 5% skim milk in TBST, and was washed 3 times with TBST. The binding of GSK3beta was detected with rabbit anti-GSK3beta antibody and secondary HRP-conjugated goat anti-rabbit IgG (Pierce).
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
Cytosolic overexpression of the LRP6 constructs in HepG2 cells. HepG2 cells in which control (empty vector, EV, encoding only GFP), miniCL and miniCLMT were transfected as GFP fusion proteins. Control, miniCL and miniCLMT were detected through the green fluorescence from GFP. beta-Catenin was detected using an anti-beta-catenin antibody, and the nuclei were detected by DAPI staining.
###end p 68
###begin p 69
(0.91 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
Western blotting analysis from the transfected HepG2 cells. Labels at the left side of blots indicate the antibody used for detection of the corresponding protein. The endogenous beta-catenin level was detected by an anti-beta-catenin antibody. p-GS indicates the level of the phosphorylated GS by GSK3beta, detected by anti-glycogen synthase (Ser641) antibody. p-S9-GSK3beta indicates the phosphorylated Ser9 of GSK3beta, and was detected by anti-phospho GSK3beta (Ser9) antibody. Levels of transfected proteins were detected using monoclonal GFP antibody, indicated by GFP. Pan-Ras is shown as a loading control.
###end p 71
###begin p 72
(0.05 MB TIF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 316 322 304 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2</xref>
In vitro GSK3beta activity assay based on band-shifts. The numbers at the right indicate the numbers of the incorporated phosphate groups by CK1 or GSK3beta. We used unphosphorylated beta-catenin 1-133 region (0) as a substrate, and CK1 and GSK3beta proteins were sequentially treated in the reaction buffer used in Fig. 2. The bands for GSK3beta substrate is indicated by "substrate", and the product bands are indicated by "product a" and "product b". The bands were visualized by Coomassie staining.
###end p 74
###begin p 75
(0.16 MB TIF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 253 259 241 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2</xref>
###xml 743 750 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s001">Fig. S1</xref>
###xml 755 762 737 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s002">Fig. S2</xref>
In vitro GSK3beta kinase assay based on the phospho-specific antibodies against beta-catenin. Unphosphorylated beta-catenin 1-133 region (0) was used as a substrate, and CK1 and/or GSK3beta was treated simultaneously in the same reaction buffer used in Fig. 2. To confirm the inhibitory role of the PPPSPxS peptides, each peptide was added to the reaction mixture. SDS-PAGE was applied to analyze the result. One of gels was stained by Coomassie blue (Top), the other two gels were transferred to PVDF membranes. One membrane was visualized using anti-phospho-beta-catenin (Ser45) antibody (Middle), and the other membrane was visualized using anti-phospho-beta-catenin (Ser33/37/Thr41) antibody (Bottom). The results are well-consistent with Fig. S1 and Fig. S2, which confirms the fidelity of the in vitro kinase assay used in this study.
###end p 77
###begin p 78
(0.23 MB TIF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 16 23 16 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2A</xref>
Gel figures for Fig. 2A. The bands labeled "substrate" are the prephosphorylated beta-catenin 1-133 fragment by CK1. The two product bands are indicated.
###end p 80
###begin p 81
(0.49 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 16 23 16 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2C</xref>
###xml 402 409 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004046.s002">Fig. S2</xref>
Gel figures for Fig. 2C. The bands labeled substrate are the unphosphorylated Axin fragment, and the band labeled product is the Axin fragment harboring phosphorylation at Ser614. Prior to the experiment, we found that the GSK3beta-mediated phosphorylation of the Axin fragment can be detected through a band upshift of the fragment on an SDS-polyacrylamide gel. The reaction buffer was the same as in Fig. S2, and the incubation time was 1 hour. In a control experiment, the primed beta-catenin (1-133) was used as a substrate using the same amount of GSK3beta and reaction buffer, but was incubated for 15 min (See the "control" lanes in the first gel).
###end p 83
###begin p 84
(0.22 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 25 32 25 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004046-g002">Fig. 2D</xref>
A representative gel for Fig. 2D.
###end p 86
###begin p 87
(0.11 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
References
###end title 89
###begin article-title 90
Mechanisms of Wnt signaling in development.
###end article-title 90
###begin article-title 91
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.
###end article-title 91
###begin article-title 92
beta-catenin is a target for the ubiquitin-proteasome pathway.
###end article-title 92
###begin article-title 93
Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin.
###end article-title 93
###begin article-title 94
Armadillo/beta-catenin signals in the nucleus-proof beyond a reasonable doubt?
###end article-title 94
###begin article-title 95
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.
###end article-title 95
###begin article-title 96
A mechanism for Wnt coreceptor activation.
###end article-title 96
###begin article-title 97
Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
###end article-title 97
###begin article-title 98
Multiplicity of the interactions of Wnt proteins and their receptors.
###end article-title 98
###begin article-title 99
Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.
###end article-title 99
###begin article-title 100
Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation.
###end article-title 100
###begin article-title 101
Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction.
###end article-title 101
###begin article-title 102
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
###end article-title 102
###begin article-title 103
LRP6 mutation in a family with early coronary disease and metabolic risk factors.
###end article-title 103
###begin article-title 104
Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
###end article-title 104
###begin article-title 105
The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity.
###end article-title 105
###begin article-title 106
LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
###end article-title 106
###begin article-title 107
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling.
###end article-title 107
###begin article-title 108
Target protease specificity of the viral serpin CrmA. Analysis of five caspases.
###end article-title 108
###begin article-title 109
Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.
###end article-title 109
###begin article-title 110
A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
###end article-title 110
###begin article-title 111
Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
###end article-title 111
###begin article-title 112
A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
###end article-title 112
###begin article-title 113
Dorsal downregulation of GSK3beta by a non-Wnt-like mechanism is an early molecular consequence of cortical rotation in early Xenopus embryos.
###end article-title 113
###begin article-title 114
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
###end article-title 114
###begin article-title 115
A single BIR domain of XIAP sufficient for inhibiting caspases.
###end article-title 115
###begin article-title 116
The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity.
###end article-title 116
###begin article-title 117
A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling.
###end article-title 117
###begin article-title 118
Domains of axin and disheveled required for interaction and function in wnt signaling.
###end article-title 118
###begin article-title 119
###xml 129 139 <span type="species:ncbi:7227">Drosophila</span>
Accumulation of Armadillo induced by Wingless, Dishevelled, and dominant-negative Zeste-White 3 leads to elevated DE-cadherin in Drosophila clone 8 wing disc cells.
###end article-title 119
###begin article-title 120
Regulation of protein kinases in insulin, growth factor and Wnt signalling.
###end article-title 120
###begin article-title 121
Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
###end article-title 121
###begin article-title 122
A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage.
###end article-title 122
###begin article-title 123
Identification of the Axin and Frat binding region of glycogen synthase kinase-3.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This project was supported by a Korea Research Foundation Grant (KRF-2007-C00620) to N-C.H. and by U.S. National Institutes of Health grant GM56169 to W.I.W. The Basic Research Program of the Korea Science & Engineering Foundation (R01-2006-000-10521-0), and The Advanced Basic Research Laboratory Program (R14-2002-012-01001-0) of KRF partly supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 125

